Not a good buy right now: the trend is firmly bearish (SMA_200 > SMA_20 > SMA_5) and pre-market is down -6.79% to 2.47.
With no Intellectia AI Stock Picker or SwingMax buy signal, there’s no high-conviction timing edge for an impatient entry.
Best call is to avoid/stand aside until price reclaims key levels (at minimum back above S1 ~2.567 and ideally toward pivot ~3.06), otherwise downside risk remains elevated.
Pre-market price: 2.47, which is below S1 (2.567) and near S2 (2.262) — weakness into support suggests sellers still control the tape.
Moving averages: Bearish alignment (SMA_200 > SMA_20 > SMA_5) indicates a downtrend across long-, mid-, and short-term horizons.
MACD: Histogram -0.0464 (below 0) and negatively contracting — bearish momentum persists, only a mild slowing of downside pressure.
RSI_6: 29.917 — near oversold territory; this can support a short-term bounce, but by itself is not a reliable buy trigger in a strong downtrend.
Key levels: Resistance at pivot 3.06 then R1 3.552; support at S2 2.262. Current price is in a vulnerable zone unless it quickly regains S1 (2.567).
Pattern-based projection provided: ~70% chance of -0.29% next day, +3.16% next week, +4.83% next month — near-term edge is not favorable, and any upside is more “bounce” than “trend reversal.”
Positive Catalysts
increases odds of a reflex bounce if support (2.262–2.
Net income: -708,991 (down -47.30% YoY) — losses widened meaningfully.
EPS: -0.39 (down -48.00% YoY) — profitability trend is deteriorating.
Gross margin: 14.85% (up +19.66% YoY) — margin improvement, but not enough to offset worsening net results.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the data (implying limited/none recent coverage signals here).
Wall Street-style pro view (based on provided fundamentals): gross margin improvement is a positive datapoint.
Wall Street-style con view: declining revenue and significantly worsening net income/EPS in 2025/Q3 outweigh the margin improvement, making the risk/reward unattractive right now.
Influential/flow checks: Hedge funds neutral; insiders neutral; no recent Congress trading data available.
Wall Street analysts forecast BGLC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGLC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast BGLC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGLC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
